Abstract
Alzheimer’s disease (AD) has been one of the most prevalent health problems among senior population. Interleukin-1A (IL-1A) and IL-1B are two isoforms of IL-1. Recent studies suggested that certain polymorphisms on these two genes are associated with AD. Bridging integrator 1 (BIN1) is considered as common genetic risk factors for AD, whereas different studies have provided various conclusions regarding its role in AD. This study was designed to justify the association between multiple gene polymorphisms and AD through an evidence synthesis approach. We conducted a literature search to identify relevant articles published from 2000 to 2015 from PubMed, Embase, and Cochrane Library, in accordance with inclusion criteria. Pooled odds ratios (ORs) were calculated for the allele model. The effect estimates were summarized by both standard and cumulative meta-analysis. Finally, 54 articles with 88 independent studies were enrolled in this meta-analysis. Mutants in rs1800587 of IL-1A, rs1143634 of IL-1B, rs12989701, and rs744373 of BIN1 were significantly associated with AD onset. The difference effect of same single nucleotide polymorphisms (SNPs) on various ethnicities was also observed in our results. The present meta-analysis suggested that IL-1A, IL-1B, and BIN1 were candidate genes for AD pathogenesis. Polymorphisms of IL-1A, IL-1B, and BIN1 are associated with AD onset.
Similar content being viewed by others
References
Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM (2007) Forecasting the global burden of Alzheimer’s disease. Alzheimers Dement : J Alzheimers Assoc 3(3):186–191. doi:10.1016/j.jalz.2007.04.381
Yang YH, Hsu CL, Chou MC, Kasai M, Meguro K, Liu CK (2015) Early symptoms of Alzheimer’s disease in Japan and Taiwan. Geriatr Gerontol Int. doi:10.1111/ggi.12557
Armstrong RA (2014) A critical analysis of the ‘amyloid cascade hypothesis’. Folia Neuropathol / Assoc Polish Neuropathol Med Res Cent Polish Acad Sci 52(3):211–225
Small SA, Duff K (2008) Linking Aβ and Tau in late-onset Alzheimer’s disease: a dual pathway hypothesis. Neuron 60(4):534–542. doi:10.1016/j.neuron.2008.11.007
Sato N, Morishita R (2013) Roles of vascular and metabolic components in cognitive dysfunction of Alzheimer disease: short- and long-term modification by non-genetic risk factors. Front Aging Neurosci 5:64. doi:10.3389/fnagi.2013.00064
Chowdhury TA (2010) Diabetes and cancer. QJM : Mon J Assoc Physicians 103(12):905–915. doi:10.1093/qjmed/hcq149
Candeias E, Duarte AI, Carvalho C, Correia SC, Cardoso S, Santos RX, Placido AI, Perry G et al (2012) The impairment of insulin signaling in Alzheimer’s disease. IUBMB Life 64(12):951–957. doi:10.1002/iub.1098
Guerreiro R, Bras J, Hardy J (2013) SnapShot: genetics of Alzheimer’s disease. Cell 155(4):968–968.e961. doi:10.1016/j.cell.2013.10.037
Karch CM, Goate AM (2015) Alzheimer’s disease risk genes and mechanisms of disease pathogenesis. Biol Psychiatry 77(1):43–51. doi:10.1016/j.biopsych.2014.05.006
Dursun E, Gezen-Ak D, Ertan T, Bilgic B, Gurvit H, Emre M, Eker E, Engin F et al (2009) Interleukin-1alpha -889 C/T polymorphism in Turkish patients with late-onset Alzheimer’s disease. Dement Geriatr Cogn Disord 27(1):82–87. doi:10.1159/000193627
Du Y, Dodel RC, Eastwood BJ, Bales KR, Gao F, Lohmuller F, Muller U, Kurz A et al (2000) Association of an interleukin 1 alpha polymorphism with Alzheimer’s disease. Neurology 55(4):480–483
Mrak RE, Griffin WS (2001) Interleukin-1, neuroinflammation, and Alzheimer’s disease. Neurobiol Aging 22(6):903–908
Hurme M, Lahdenpohja N, Santtila S (1998) Gene polymorphisms of interleukins 1 and 10 in infectious and autoimmune diseases. Ann Med 30(5):469–473
Grimaldi LM, Casadei VM, Ferri C, Veglia F, Licastro F, Annoni G, Biunno I, De Bellis G et al (2000) Association of early-onset Alzheimer’s disease with an interleukin-1alpha gene polymorphism. Ann Neurol 47(3):361–365
Minster RL, DeKosky ST, Ganguli M, Belle S, Kamboh MI (2000) Genetic association studies of interleukin-1 (IL-1A and IL-1B) and interleukin-1 receptor antagonist genes and the risk of Alzheimer’s disease. Ann Neurol 48(5):817–819
Nicoll JA, Mrak RE, Graham DI, Stewart J, Wilcock G, MacGowan S, Esiri MM, Murray LS et al (2000) Association of interleukin-1 gene polymorphisms with Alzheimer’s disease. Ann Neurol 47(3):365–368
Rebeck GW (2000) Confirmation of the genetic association of interleukin-1A with early onset sporadic Alzheimer’s disease. Neurosci Lett 293(1):75–77
Ki CS, Na DL, Kim DK, Kim HJ, Kim JW (2001) Lack of association of the interleukin-1alpha gene polymorphism with Alzheimer’s disease in a Korean population. Ann Neurol 49(6):817–818
Prince JA, Feuk L, Sawyer SL, Gottfries J, Ricksten A, Nagga K, Bogdanovic N, Blennow K et al (2001) Lack of replication of association findings in complex disease: an analysis of 15 polymorphisms in prior candidate genes for sporadic Alzheimer’s disease. Eur J Hum Genet : EJHG 9(6):437–444. doi:10.1038/sj.ejhg.5200651
Combarros O, Sanchez-Guerra M, Infante J, Llorca J, Berciano J (2002) Gene dose-dependent association of interleukin-1A [-889] allele 2 polymorphism with Alzheimer’s disease. J Neurol 249(9):1242–1245. doi:10.1007/s00415-002-0819-9
Fidani L, Goulas A, Mirtsou V, Petersen RC, Tangalos E, Crook R, Hardy J (2002) Interleukin-1A polymorphism is not associated with late onset Alzheimer’s disease. Neurosci Lett 323(1):81–83
Green EK, Harris JM, Lemmon H, Lambert JC, Chartier-Harlin MC, St Clair D, Mann DM, Iwatsubo T et al (2002) Are interleukin-1 gene polymorphisms risk factors or disease modifiers in AD? Neurology 58(10):1566–1568
Hedley R, Hallmayer J, Groth DM, Brooks WS, Gandy SE, Martins RN (2002) Association of interleukin-1 polymorphisms with Alzheimer’s disease in Australia. Ann Neurol 51(6):795–797. doi:10.1002/ana.10196
Mattila E, Rinne JO, Lehtimäki T, Röyttä M, Ahonen J-P, Hurme M (2002) Association of an interleukin 1B gene polymorphism (-511) with Parkinson’s disease in Finnish patients. J Med Genet 39:400–402
Pirskanen M, Hiltunen M, Mannermaa A, Iivonen S, Helisalmi S, Lehtovirta M, Koivisto AM, Laakso M et al (2002) Interleukin 1 alpha gene polymorphism as a susceptibility factor in Alzheimer’s disease and its influence on the extent of histopathological hallmark lesions of Alzheimer’s disease. Dement Geriatr Cogn Disord 14(3):123–127
Clarimon J, Bertranpetit J, Calafell F, Boada M, Tarraga L, Comas D (2003) Joint analysis of candidate genes related to Alzheimer’s disease in a Spanish population. Psychiatr Genet 13(2):85–90. doi:10.1097/01.ypg.0000056174.32550.7e
Ehl C, Kolsch H, Ptok U, Jessen F, Schmitz S, Frahnert C, Schlosser R, Rao ML et al (2003) Association of an interleukin-1beta gene polymorphism at position -511 with Alzheimer’s disease. Int J Mol Med 11(2):235–238
Kuo YM, Liao PC, Lin C, Wu CW, Huang HM, Lin CC, Chuo LJ (2003) Lack of association between interleukin-1alpha polymorphism and Alzheimer disease or vascular dementia. Alzheimer Dis Assoc Disord 17(2):94–97
Ma SL, Tang NLS, Lam LCW, Chiu HFK (2003) Lack of Association of the interleukin-1beta gene polymorphism with Alzheimer’s disease in a Chinese Population. Dement Geriatr Cogn Disord 16(4):265–268. doi:10.1159/000072811
McCarron MO, Stewart J, McCarron P, Love S, Vinters HV, Ironside JW, Mann DM, Graham DI et al (2003) Association between interleukin-1A polymorphism and cerebral amyloid angiopathy-related hemorrhage. Stroke J Cereb Circ 34(10):e193–e195. doi:10.1161/01.STR.0000089294.85447.1E
Sciacca FL, Ferri C, Licastro F, Veglia F, Biunno I, Gavazzi A, Calabrese E, Martinelli Boneschi F et al (2003) Interleukin-1B polymorphism is associated with age at onset of Alzheimer’s disease. Neurobiol Aging 24(7):927–931
Tsai SJ, Liu HC, Liu TY, Wang KY, Hong CJ (2003) Lack of association between the interleukin-1alpha gene C(-889)T polymorphism and Alzheimer’s disease in a Chinese population. Neurosci Lett 343(2):93–96
Bosco P (2004) Association of IL-1 RN*2 allele and methionine synthase 2756 AA genotype with dementia severity of sporadic Alzheimer’s disease. J Neurol Neurosurg Psychiatry 75(7):1036–1038. doi:10.1136/jnnp.2003.025866
Hayes A, Green EK, Pritchard A, Harris JM, Zhang Y, Lambert JC, Chartier-Harlin MC, Pickering-Brown SM et al (2004) A polymorphic variation in the interleukin 1A gene increases brain microglial cell activity in Alzheimer’s disease. J Neurol Neurosurg Psychiatry 75(10):1475–1477. doi:10.1136/jnnp.2003.030866
Li XQ, Zhang JW, Zhang ZX, Chen D, Qu QM (2004) Interleukin-1 gene cluster polymorphisms and risk of Alzheimer’s disease in Chinese Han population. J Neural Transm 111(9):1183–1190. doi:10.1007/s00702-004-0148-5
McCulley MC, Day IN, Holmes C (2004) Association between interleukin 1-beta promoter (-511) polymorphism and depressive symptoms in Alzheimer’s disease. Am J Med Genet B Neuropsychiatr Genet : Off Publ Int Soc Psychiatr Genet 124B(1):50–53. doi:10.1002/ajmg.b.20086
Nishimura M, Sakamoto T, Kaji R, Kawakami H (2004) Influence of polymorphisms in the genes for cytokines and glutathione S-transferase omega on sporadic Alzheimer’s disease. Neurosci Lett 368(2):140–143. doi:10.1016/j.neulet.2004.06.076
Rosenmann H, Meiner Z, Dresner-Pollak R, Kahana E, Aladjem Z, Grenader T, Wertman E, Abramsky O (2004) Lack of association of interleukin-1beta polymorphism with Alzheimer’s disease in the Jewish population. Neurosci Lett 363(2):131–133. doi:10.1016/j.neulet.2004.03.063
Tang MN, Zhang ZX, Han HY, Liu XH, Shen Y (2004) Analysis on association between the polymorphisms in apolipoprotein E, interleukin-1 alpha genes and Alzheimer’s disease in Chengdu area. Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chin J Med Genet 21(2):176–178
Seripa D, Matera MG, Dal Forno G, Gravina C, Masullo C, Daniele A, Binetti G, Bonvicini C et al (2005) Genotypes and haplotypes in the IL-1 gene cluster: analysis of two genetically and diagnostically distinct groups of Alzheimer patients. Neurobiol Aging 26(4):455–464. doi:10.1016/j.neurobiolaging.2004.04.001
Wang WF, Liao YC, Wu SL, Tsai FJ, Lee CC, Hua CS (2005) Association of interleukin-I beta and receptor antagonist gene polymorphisms with late onset Alzheimer’s disease in Taiwan Chinese. Eur J Neurol 12(8):609–613. doi:10.1111/j.1468-1331.2005.01033.x
Ravaglia G, Paola F, Maioli F, Martelli M, Montesi F, Bastagli L, Bianchin M, Chiappelli M et al (2006) Interleukin-1beta and interleukin-6 gene polymorphisms as risk factors for AD: a prospective study. Exp Gerontol 41(1):85–92. doi:10.1016/j.exger.2005.10.005
Wehr H, Bednarska-Makaruk M, Lojkowska W, Graban A, Hoffman-Zacharska D, Kuczynska-Zardzewialy A, Mrugala J, Rodo M et al (2006) Differences in risk factors for dementia with neurodegenerative traits and for vascular dementia. Dement Geriatr Cogn Disord 22(1):1–7. doi:10.1159/000092845
Zhou YT, Zhang ZX, Zhang JW, He XM, Xu T (2006) Association between interleukin-1 alpha-889 C/T polymorphism and Alzheimer’s disease in Chinese Han population. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 28(2):186–190
Wang HK, Hsu WC, Fung HC, Lin JC, Hsu HP, Wu YR, Hsu Y, Hu FJ et al (2007) Interleukin-1alpha and -1beta promoter polymorphisms in Taiwanese patients with dementia. Dement Geriatr Cogn Disord 24(2):104–110. doi:10.1159/000104829
Deniz-Naranjo MC, Munoz-Fernandez C, Alemany-Rodriguez MJ, Perez-Vieitez MC, Aladro-Benito Y, Irurita-Latasa J, Sanchez-Garcia F (2008) Cytokine IL-1 beta but not IL-1 alpha promoter polymorphism is associated with Alzheimer disease in a population from the Canary Islands, Spain. Eur J Neurol 15(10):1080–1084. doi:10.1111/j.1468-1331.2008.02252.x
Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, Pahwa JS, Moskvina V et al (2009) Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer’s disease. Nat Genet 41(10):1088–1093. doi:10.1038/ng.440
Hu JL, Li G, Zhou DX, Zou YX, Zhu ZS, Xu RX, Jiang XD, Zeng YJ (2009) Genetic analysis of interleukin-1A C(-889)T polymorphism with Alzheimer disease. Cell Mol Neurobiol 29(1):81–85. doi:10.1007/s10571-008-9299-5
Klimkowicz-Mrowiec A, Marona M, Wolkow P, Maruszak A, Styczynska M, Barcikowska M, Zekanowski C, Szczudlik A et al (2009) Interleukin-1 gene-511 CT polymorphism and the risk of Alzheimer’s disease in a Polish population. Dement Geriatr Cogn Disord 28(5):461–464. doi:10.1159/000259460
Serretti A, Olgiati P, Politis A, Malitas P, Albani D, Dusi S, Polito L, De Mauro S et al (2009) Lack of association between interleukin-1 alpha rs1800587 polymorphism and Alzheimer’s disease in two independent European samples. J Alzheimers Dis : JAD 16(1):181–187. doi:10.3233/JAD-2009-0946
Ribizzi G, Fiordoro S, Barocci S, Ferrari E, Megna M (2010) Cytokine polymorphisms and Alzheimer disease: possible associations. Neurol Sci : Off J Ital Neurol Soc Ital Soc Clin Neurophysiol 31(3):321–325. doi:10.1007/s10072-010-0221-9
Carrasquillo MM, Belbin O, Hunter TA, Ma L, Bisceglio GD, Zou F, Crook JE, Pankratz VS et al (2011) Replication of BIN1 association with Alzheimer’s disease and evaluation of genetic interactions. J Alzheimers Dis : JAD 24(4):751–758. doi:10.3233/JAD-2011-101932
Cousin E, Mace S, Rocher C, Dib C, Muzard G, Hannequin D, Pradier L, Deleuze JF et al (2011) No replication of genetic association between candidate polymorphisms and Alzheimer’s disease. Neurobiol Aging 32(8):1443–1451. doi:10.1016/j.neurobiolaging.2009.09.004
Hu X, Pickering E, Liu YC, Hall S, Fournier H, Katz E, Dechairo B, John S et al (2011) Meta-analysis for genome-wide association study identifies multiple variants at the BIN1 locus associated with late-onset Alzheimer’s disease. PLoS ONE 6(2), e16616. doi:10.1371/journal.pone.0016616
Lambert JC, Zelenika D, Hiltunen M, Chouraki V, Combarros O, Bullido MJ, Tognoni G, Fievet N et al (2011) Evidence of the association of BIN1 and PICALM with the AD risk in contrasting European populations. Neurobiol Aging 32(4):756 e711–755. doi:10.1016/j.neurobiolaging.2010.11.022
Vendramini AA, de Labio RW, Rasmussen LT, Dos Reis NM, Minett T, Bertolucci PH, de Souza Pinhel MA, Souza DR et al (2011) Interleukin-8-251T > A, interleukin-1alpha-889C > T and apolipoprotein E polymorphisms in Alzheimer’s disease. Genet Mol Biol 34(1):1–5. doi:10.1590/S1415-47572010005000098
Ohara T, Ninomiya T, Hirakawa Y, Ashikawa K, Monji A, Kiyohara Y, Kanba S, Kubo M (2012) Association study of susceptibility genes for late-onset Alzheimer’s disease in the Japanese population. Psychiatr Genet 22(6):290–293. doi:10.1097/YPG.0b013e3283586215
Payao SL, Goncalves GM, de Labio RW, Horiguchi L, Mizumoto I, Rasmussen LT, de Souza Pinhel MA, Silva Souza DR et al (2012) Association of interleukin 1beta polymorphisms and haplotypes with Alzheimer’s disease. J Neuroimmunol 247(1-2):59–62. doi:10.1016/j.jneuroim.2012.03.012
Tan L, Yu JT, Zhang W, Wu ZC, Zhang Q, Liu QY, Wang W, Wang HF et al (2013) Association of GWAS-linked loci with late-onset Alzheimer’s disease in a northern Han Chinese population. Alzheimers Dement : J Alzheimers Assoc 9(5):546–553. doi:10.1016/j.jalz.2012.08.007
Carrasquillo MM, Khan Q, Murray ME, Krishnan S, Aakre J, Pankratz VS, Nguyen T, Ma L et al (2014) Late-onset Alzheimer disease genetic variants in posterior cortical atrophy and posterior AD. Neurology 82(16):1455–1462. doi:10.1212/WNL.0000000000000335
Flex A, Giovannini S, Biscetti F, Liperoti R, Spalletta G, Straface G, Landi F, Angelini F et al (2014) Effect of proinflammatory gene polymorphisms on the risk of Alzheimer’s disease. Neurodegener Dis 13(4):230–236. doi:10.1159/000353395
Omoumi A, Fok A, Greenwood T, Sadovnick AD, Feldman HH, Hsiung GY (2014) Evaluation of late-onset Alzheimer disease genetic susceptibility risks in a Canadian population. Neurobiol Aging 35(4):936 e935–912. doi:10.1016/j.neurobiolaging.2013.09.025
Wang HZ, Bi R, Hu QX, Xiang Q, Zhang C, Zhang DF, Zhang W, Ma X et al (2014) Validating GWAS-identified risk loci for Alzheimer’s disease in Han Chinese populations. Mol Neurobiol. doi:10.1007/s12035-014-9015-z
Li HL, Yang P, Liu ZJ, Sun YM, Lu SJ, Tao QQ, Guo QH, Wu ZY (2015) Common variants at Bin1 are associated with sporadic Alzheimer’s disease in the Han Chinese population. Psychiatr Genet 25(1):21–25. doi:10.1097/YPG.0000000000000071
Rezazadeh M, Khorrami A, Yeghaneh T, Talebi M, Kiani SJ, Heshmati Y, Gharesouran J (2015) Genetic factors affecting late-anset Alzheimer’s disease susceptibility. Neruomol Med. doi:10.1007/s12017-015-8376-4
Tian M, Deng YY, Hou DR, Li W, Feng XL, Yu ZL (2015) Association of IL-1, IL-18, and IL-33 gene polymorphisms with late-onset Alzheimers disease in a Hunan Han Chinese population. Brain Res 1596:136–145. doi:10.1016/j.brainres.2014.11.019
Weber A, Wasiliew P, Kracht M (2010) Interleukin-1 (IL-1) pathway. Science signaling 3 (105):cm1. doi:10.1126/scisignal.3105cm1
Dursun E, Gezen-Ak D, Hanagasi H, Bilgic B, Lohmann E, Ertan S, Atasoy IL, Alaylioglu M et al (2015) The interleukin 1 alpha, interleukin 1 beta, interleukin 6 and alpha-2-macroglobulin serum levels in patients with early or late onset Alzheimer’s disease, mild cognitive impairment or Parkinson’s disease. J Neuroimmunol 283:50–57. doi:10.1016/j.jneuroim.2015.04.014
Zhu XC, Tan L, Jiang T, Tan MS, Zhang W, Yu JT (2014) Association of IL-12A and IL-12B polymorphisms with Alzheimer’s disease susceptibility in a Han Chinese population. J Neuroimmunol 274(1-2):180–184. doi:10.1016/j.jneuroim.2014.06.026
Hua Y, Zhao H, Kong Y, Lu X (2012) Meta-analysis of the association between the interleukin-1A -889C/T polymorphism and Alzheimer’s disease. J Neurosci Res 90(9):1681–1692. doi:10.1002/jnr.23062
Li BH, Zhang LL, Yin YW, Pi Y, Guo L, Yang QW, Gao CY, Fang CQ et al (2013) Association between interleukin-1alpha C(-889)T polymorphism and Alzheimer’s disease: a meta-analysis including 12,817 subjects. J Neural Transm 120(3):497–506. doi:10.1007/s00702-012-0867-y
Qin X, Peng Q, Zeng Z, Chen Z, Lin L, Deng Y, Huang X, Xu J et al (2012) Interleukin-1A -889C/T polymorphism and risk of Alzheimer’s disease: a meta-analysis based on 32 case-control studies. J Neurol 259(8):1519–1529. doi:10.1007/s00415-011-6381-6
Rainero I, Bo M, Ferrero M, Valfre W, Vaula G, Pinessi L (2004) Association between the interleukin-1alpha gene and Alzheimer’s disease: a meta-analysis. Neurobiol Aging 25(10):1293–1298. doi:10.1016/j.neurobiolaging.2004.02.011
Yuan H, Xia Q, Ge P, Wu S (2013) Genetic polymorphism of interleukin 1beta -511C/T and susceptibility to sporadic Alzheimer’s disease: a meta-analysis. Mol Biol Rep 40(2):1827–1834. doi:10.1007/s11033-012-2237-0
Karch CM, Jeng AT, Nowotny P, Cady J, Cruchaga C, Goate AM (2012) Expression of novel Alzheimer’s disease risk genes in control and Alzheimer’s disease brains. PLoS ONE 7(11), e50976. doi:10.1371/journal.pone.0050976
Gan-Or Z, Amshalom I, Bar-Shira A, Gana-Weisz M, Mirelman A, Marder K, Bressman S, Giladi N et al (2015) The Alzheimer disease BIN1 locus as a modifier of GBA-associated Parkinson disease. J Neurol 262(11):2443–2447. doi:10.1007/s00415-015-7868-3
Liu G, Zhang S, Cai Z, Li Y, Cui L, Ma G, Jiang Y, Zhang L et al (2013) BIN1 gene rs744373 polymorphism contributes to Alzheimer’s disease in East Asian population. Neurosci Lett 544:47–51. doi:10.1016/j.neulet.2013.02.075
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Figure S1
Cumulative meta-analysis of rs1143627 polymorphism in IL-1B gene (GIF 8 kb)
Figure S2
Cumulative meta-analysis of rs16944 polymorphism in IL-1B gene (GIF 27 kb)
Figure S3
Cumulative meta-analysis of rs7561528 polymorphism in BIN1 gene (GIF 6 kb)
Figure S4
Funnel plot of publication bias for rs1800587 polymorphism in IL-1A gene (A), rs1143634 polymorphism in IL-1B gene (B), rs12989701 (C) and rs744373 (D) polymorphisms in BIN1 gene (GIF 83 kb)
ESM 5
(DOCX 24 kb)
Rights and permissions
About this article
Cite this article
Dong, X., Zhang, L., Meng, Q. et al. Association Between Interleukin-1A, Interleukin-1B, and Bridging integrator 1 Polymorphisms and Alzheimer’s Disease: a standard and Cumulative Meta-analysis. Mol Neurobiol 54, 736–747 (2017). https://doi.org/10.1007/s12035-015-9683-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12035-015-9683-3